Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
61.27
+0.14 (0.23%)
Aug 29, 2025, 4:00 PM - Market closed
Globus Medical Stock Forecast
Stock Price Forecast
The 10 analysts that cover Globus Medical stock have a consensus rating of "Buy" and an average price target of $87.3, which forecasts a 42.48% increase in the stock price over the next year. The lowest target is $66 and the highest is $115.
Price Target: $87.3 (+42.48%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Globus Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
Buy | 5 | 5 | 5 | 5 | 5 | 5 |
Hold | 4 | 4 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 13 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wells Fargo | Wells Fargo | Buy Maintains $76 → $66 | Buy | Maintains | $76 → $66 | +7.72% | Aug 8, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $97 → $90 | Strong Buy | Maintains | $97 → $90 | +46.89% | Jul 22, 2025 |
Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 21, 2025 |
Morgan Stanley | Morgan Stanley | Buy Maintains $75 → $68 | Buy | Maintains | $75 → $68 | +10.98% | Jul 15, 2025 |
JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 27, 2025 |
Financial Forecast
Revenue This Year
2.91B
from 2.52B
Increased by 15.55%
Revenue Next Year
3.14B
from 2.91B
Increased by 7.97%
EPS This Year
3.27
from 0.75
Increased by 336.21%
EPS Next Year
3.74
from 3.27
Increased by 14.18%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 3.0B | 3.3B | ||
Avg | 2.9B | 3.1B | ||
Low | 2.8B | 2.9B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 20.1% | 14.2% | ||
Avg | 15.5% | 8.0% | ||
Low | 10.4% | 1.2% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 3.42 | 4.36 | ||
Avg | 3.27 | 3.74 | ||
Low | 3.09 | 3.31 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 356.4% | 33.2% | ||
Avg | 336.2% | 14.2% | ||
Low | 311.6% | 1.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.